Altesa BioSciences, a clinical-stage pharmaceutical company dedicated to improving the lives of people with chronic lung diseases including COPD and asthma, demonstrated positive results from its ...
About 40% of at-risk patients with COPD did not receive maintenance therapy despite having frequent or severe exacerbations.
Pairing vulnerable, low-income patients with asthma coaches can improve outcomes and may also reduce costs associated with ...
Like high blood pressure, fatty liver disease has a way of sneaking up on people, often not causing noticeable symptoms until ...
Among hospitalized adults with acute exacerbation of COPD, pegtarazimod improved oxygen utilization and inflammatory ...
A large new study presented at the 2026 ATS International Conference shows that patients treated for COPD or pneumonia ...
Patients with severe asthma who are typically underrepresented in clinical studies experienced improved outcomes with ...
Wendy Robinson and Gillian Cunningham, both of whom started smoking as children in Bradford, have spoken out in favour of the ...
A retired ambulance worker who went on a violent and foul-mouthed rampage on Christmas Eve after drinking beer while taking ...
The drug tezepelumab was shown to significantly reduce exacerbations in people with severe asthma in clinical trials. Now, a ...
The UK's coastal ambient air quality, often perceived as inherently healthpromoting, contrasts with the poor health outcomes ...
Spiriva is not a steroid. Learn how this bronchodilator differs from corticosteroids, how it treats asthma and COPD, and what ...